World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00932295
Date of registration: 02/07/2009
Primary sponsor: Virginia Commonwealth University
Public title: Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
Scientific title: Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
Date of first enrolment: February 2009
Target sample size: 32
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00932295
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science  
Countries of recruitment
United States
Contacts
Name:   Thomas Eissenberg, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Virginia Commonwealth University
Key inclusion & exclusion criteria

Inclusion Criteria:

Participants must be healthy, between 18 and 55 years of age, and report a cigarette
intake of > 15 cig/day for at least 1 year. They must provide an afternoon screening CO
level of > 15 ppm at intake. They must also provide a urine sample for cotinine analysis,
and receive a result of at least 4 on the urine immunoassay test strip scale (possible
range = 0-6) at intake.

Exclusion Criteria:

Exclusion criteria include: history of chronic health problems or psychiatric conditions,
breastfeeding, or pregnancy (assessed by urinalysis). Individuals who report current
attempts to quit smoking, previous experience with Crown Seven or NJOY. Individuals who
report alcohol or marijuana use greater than 20 days within the last 30 days, or recent
illicit drug use such as cocaine or heroin. Women reporting active menopause will be
excluded (menopause may cause tobacco/nicotine withdrawal-like symptoms, such as
depression, Parry et al., 2001).



Age minimum: 18 Years
Age maximum: 55 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Focus is on Cigarette Smokers.
No Conditions: This is Not a Treatment Study.
Intervention(s)
Other: CROWN SEVEN
Other: NJOY
Other: OB
Other: Sham smoking
Primary Outcome(s)
Plasma nicotine concentration (ng/ml) [Time Frame: baseline, 5, 15, 30, and 45 minutes post-use]
Secondary Outcome(s)
Heart rate [Time Frame: continuous]
Withdrawal suppression (subjective measure) [Time Frame: baseline and 5, 15, 30, and 45 minutes post-use]
Secondary ID(s)
HM11820
R01CA103827
R01CA120142
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Cancer Institute (NCI)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history